News

Novartis announced that both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company's New Drug Application (NDA) and Marketing…
Read More...

Sarepta Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Paragon Bioservices (Paragon), which will provide Sarepta access to…
Read More...

Novan announced that the Company has expanded its partnership with Sato Pharmaceutical, a Japanese company with a prescription pharmaceutical business specializing in dermatology, to…
Read More...

Amicus Therapeutics announced a major collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania (Penn) to pursue research and…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Hemlibra (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in…
Read More...

Boehringer Ingelheim and Eli Lilly and Company presented the full results of the long-term cardiovascular outcome trial, CARMELINA, which studied the impact of Trajenta (linagliptin) on…
Read More...

Evonik announced the launch of an advanced combination polymer for enteric coatings. EUDRAGIT® FL 30 D-55 leverages Evonik’s new, proprietary AEMP® technology (Advanced Excipient…
Read More...

Kite, a Gilead Company and HiFiBiO Therapeutics, a biotechnology company focused on the discovery of therapeutic antibodies through single B cell screening and analysis, announced the…
Read More...

Daiichi Sankyo Company announced that axicabtagene ciloleucel (formerly KTE-C19) has been granted Orphan Drug designation by the Japan Ministry of Health, Labour and Welfare (MHLW) for…
Read More...

Chugai Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by…
Read More...

Alnylam Pharmaceuticals announced updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting…
Read More...

Prana Biotechnology announced further pre-clinical evidence for PBT434 will be presented in a poster at the International Congress of Parkinson’s Disease and Movement Disorders in Hong…
Read More...

Evotec AG announced that it has established an initiative with Sanofi through the launch of a newly created BRIDGE, called LAB031, designed to accelerate drug discovery across multiple…
Read More...

Therapure Biomanufacturing announced approval for the manufacturing of Insmed Incorporated’s ARIKAYCE at its Mississauga facility by the U.S. Food and Drug Administration (FDA). FDA…
Read More...

CytovanceBiologics, Inc. signed a non-exclusive license with Horizon Discovery for the use of their HD-BIOP3 Suspension adapted GS null CHO K1 cells. The Horizon CHO GS -/- cell line is…
Read More...

Recipharm and Sanofi have completed the acquisition of Sanofi’s inhalation contract manufacturing business including a manufacturing facility located in Holmes Chapel, UK. The…
Read More...

Novartis announced that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates that are part…
Read More...

Aptar Pharma continues its commitment to meeting new market trends with the release of an industry first, PureHale, a new portable and ready-to-use drug delivery solution designed for…
Read More...

CytoSen Therapeutics and KBI Biopharma announced a strategic partnership to manufacture therapeutic Natural Killer (NK) cells using a proprietary and scalable, closed system…
Read More...

Dr. Reddy’s Laboratories announced the closure of the sale of its antibiotic manufacturing facility and related assets in Bristol, Tennessee to Neopharma Inc., a wholly owned subsidiary…
Read More...